Inflammation is a host defense mechanism that is activated in response to harmful substances or pathogens. However, an excessive inflammatory response is a problem in itself. Macrophages secrete inflammatory mediators such as nitric oxide (NO) or cytokines through various pathways such as the nuclear factor kappa B (NF-κB)-activated pathway after recognizing pathogen-like lipopolysaccharides (LPSs). In this study, anti-inflammatory effects of Eupatorium chinensis var. simplicifolium (EUC) extracts were investigated using LPS-stimulated RAW 264.7 macrophages. The EUC root extract significantly reduced NO production, inducible nitric oxide synthase (iNOS) expression, and cyclooxygenase-2 expression in a concentration-dependent manner. In addition, the EUC root extract reduced phosphorylation of mitogen-activated protein kinases and protein kinase B, which is upstream of NF-κB. The EUC root extract also reduced the degradation of inhibitory kappa B. These results indicate that EUC root extract exerts anti-inflammatory effects, which are mediated by inhibition of iNOS expression and the NF-κB pathway.
Introduction
Inflammation refers to the complex biological response caused by damaged cells and tissues, chemical irritants, or invading organisms such as bacteria [8, 17, 31, 34] . Macrophages, a type of immune cell, are activated by bacterial lipopolysaccharide (LPS), interferon-gamma, and granulocyte-macrophage colony-stimulating factor [24] .
Activated macrophages play an important role in inflammatory diseases by releasing various inflammatory cytokines such as IL-1β, IL-6, TNF-α as well as other inflammatory mediators such as nitric oxide (NO) and prostaglandins [1, 18, 28] . However, excessive production of inflammatory mediators can cause severe clinical symptoms, and is associated with various immune-mediated diseases such as rheumatoid arthritis [27] .
Toll-like receptors (TLR) are a class of proteins that initiate the innate immune response by recognizing the pathogen-associated molecular patterns of pathogens [1, 23] . In mammals, 13 kinds of TLR have been identified. Among these, TLR4 forms a complex with CD14 and lymphocyte antigen 96 (MD2), and thus recognizes the complex of LPS, an endotoxin on the outer membrane of gram-negative bacteria, and LPS-binding protein [7, 14, 20] . Binding of LPS induces a conformational change in TLR4, which allows it to activate protein kinases, inducing an intracellular signaling cascade [24] . Two different types of pathways can be activated upon binding of LPS to the TLR4 receptor: myeloid differentiation primary response gene 88 (MyD88)-dependent pathways, and MyD88-independent pathways [8] . Some examples of these pathways are the mitogen activated protein kinase (MAPK) pathway, nuclear factor kappa B (NF-κB) pathway, and phosphatidylinositol 3-kinase/protein kinase B (PI3K/Akt) pathway [33, 35] .
MAPKs regulate inflammatory and immune responses by activating transcription factors such as activator protein-1, activating transcription factor-2, and NF-κB [20] .
Extracellular signal-regulated kinases (ERKs), Jun N-terminal kinases/stress-activated protein kinases, and p38 kinases are all examples of MAPKs associated with LPS-induced expression of inducible nitric-oxide synthase (iNOS) and cyclooxygenase-2 (COX-2) in mouse macrophages [32] .
NF-κB is a transcription factor that induces expression of inflammatory genes [2] . It preexists in the cytoplasm bound by inhibitory kappa B (IκB), which maintains it in an inactive state [27] . When an appropriate signal is received, phosphorylation and degradation of IκB occur, which results in the activation of NF-κB and its translocation into the nucleus [25] . Akt is a component of several pathways in the cell. This protein phosphorylates Thr23 of IκB kinase, which is also associated with the activation of NF-κB [11, 12, 30] .
Activated and translocated NF-κB subunits in the nucleus bind to NF-κB binding sites, and induce transcription of pro-inflammatory mediators such as iNOS, COX-2, TNF-α, IL-1β, and IL-6 [21] .
Nitric oxide is a free radical species produced by activated macrophage that has activity against pathogenic microbes and tumor cells [22, 26] . iNOS, a type of NO synthase (NOS), produces high concentrations of NO compared to neuronal or endothelial NOS [15, 16] . NO promotes inflammatory responses in several inflammatory diseases such as chronic inflammation, sepsis, and even death [6] . COX-2, an enzyme necessary for the synthesis of prostaglandins, is also associated with inflammatory responses [32] .
Eupatorium chinensis var. simplicifolium (EUC) is a perennial plant in the family Asteraceae that has a wide distribution in Asia. This plant is used in Korean folklore medicine to treat various diseases such as influenza, acute bronchitis, rheumatoid disease, circulatory disease, skin disease, and constipation. However, the pharmacological mechanisms of this plant are unclear.
In this paper, it was proved that EUC root extract has anti-inflammatory effects and that it functions by inhibiting the production of iNOS and COX-2 in RAW 264. Cytotoxicity assay RAW 264.7 macrophages (2×10 4 cells/ml) were seeded in 96-well plates and incubated with EUC for 23 hr at 37°C.
After incubation, cells were exposed to 10% of the volume of an EZ-Cytox kit (Daeil Lab Service Co., Ltd., Seoul, Korea)
for 1 hr at 37°C. The absorbance at 450 nm was measured using a microplate reader to assess cytotoxicity.
Western blot 
Results
Effect of EUC extracts on LPS-induced NO production in RAW 264.7 macrophages A nitric oxide assay was performed to investigate whether EUC extracts inhibited LPS-induced NO production. After stimulation of RAW 264.7 cells with LPS for 18 hr, NO production in the culture media increased markedly, to as high as 14.23±0.53 μM. The pretreatment of the cells with EUC root extract, stem extract, and flower extract, however, decreased the concentration of LPS-induced NO production to 0.81±0.16, 1.86±0.14, and 1.33±0.04 μM, respectively, compared to that produced in response to treatment with LPS alone (Fig. 1A) . In addition, if the EUC extracts themselves have a toxic effect on cells, this effect must be distinguished from that caused by NO production, which also reduces the viability of LPS-treated cells. To confirm the cell cytotoxicity of EUC, it was investigated by incubating RAW 264.7 cells with the various EUC extracts for 24 hr and then assessing cell death using the EZ-Cytox kit. The cell viability of cells pretreated with the root, stem, and flower extracts was 103.07±8.31, 53.92±1.72, and 53.92±0.97%, respectively. Both EUC stem and flower extracts were cytotoxic, but not the EUC root extract (Fig. 1B) .
In the LPS-induced RAW 264.7 cells pretreated with 25, 50, and 100 μg/ml of EUC root extract, the NO levels were 
Effect of EUC root extract on the LPS-induced expression of iNOS and COX-2 in RAW 264.7 macrophages
To investigate whether the suppression of NO production was due to the down-regulation of iNOS expression, the expression of the iNOS protein was investigated. In addition, to determine the effect of the EUC root extract on COX-2 expression, the expression levels of COX-2 protein was analyzed. iNOS expression at EUC root extract concen- trations of 25 and 50 μg/ml was mildly reduced, but it was markedly suppressed by an EUC root extract concentration of 100 μg/ml (Fig. 3A) . As a result, the EUC root extract inhibited iNOS protein expression in LPS-induced RAW 264.7 cells in a concentration-dependent manner. COX-2 expression, similar to iNOS expression, was also inhibited by EUC root extract in a concentration-dependent manner (Fig.   3B ).
Effect of the EUC root extract on the LPS-induced phosphorylation of ERK1/2 and Akt in RAW 264.7 macrophages Effect of EUC root extract on the LPS-induced degradation of IκB in RAW 264.7 macrophages
The IκB degradation was also investigated because this is a marker of activation of the NF-κB pathway. IκB protein levels were reduced by treatment with LPS alone. The EUC root extract restored IκB protein levels, however, in a concentration-dependent manner in LPS-induced RAW 264.7 macrophages (Fig. 5 ).
Discussion
The plant EUC belongs to the family Asteraceae. A number of plants of this family are traditionally used in folk medicines because of their pharmacologic effects [4, 13] . However, few studies have investigated the underlying pharmacological mechanisms [13] . Chakaravarty et al. used ethanolic leaf extracts of Eupatorium adenophorum spreng (EA), family Asteracaeae, and reported that the extracts had anti-inflammatory potential [4] . This plant grows at an altitude of 800~2050 m, and is used as an ingredient in folk remedies for treating oral and skin sores [4] . These authors showed that EA extracts increased the expression of TNF-α and inhibited that of IL-1β, COX-2, as well as decreased hydroxyl radical generation, thus the extracts had a general anti-inflammatory effect [4] . Eupatorium perfoliatum L., a North America native species widely used by native Indians, has also been shown to have anti-inflammatory effects [13] .
Extracts of this plant inhibited NO release in LPS-induced RAW 264.7 cells and downregulated the expression of chemokines (CCL2, CCL22, CXCL10) and cytokines (IL-1α, IL-1 β, and CSF-3) [13] .
NO, a secretory product of mammalian cells, carries out important functions in homeostasis and host defense [26] .
Excessive NO production, however, is associated with various diseases that involve inflammation, such as atherosclerosis, rheumatoid arthritis, and septic shock [9, 29] . Thus, inhibition of NO production in inflammatory diseases is a potentially useful treatment strategy. In this study, EUC root extract was confirmed to significantly reduce LPS-induced NO production by RAW 264.7 macrophages. This suggests that EUC root extract could potentially be used to treat inflammation. In more detail, EUC root extract reduced iNOS protein levels in a concentration-dependent manner and concentration-dependently reduced COX-2 expression, which is associated with prostaglandin production that triggers pain or swelling when overproduced. Thus, the EUC root extract interfered directly with upstream mediators in the LPS-induced iNOS and COX-2 synthesis pathways.
MAPKs have been shown to be activated by LPS-induced up-regulation of iNOS expression [5, 31] . In addition, the PI3K/Akt signal pathway is involved in NF-κB activation via IκB degradation, and LPS-activated NF-κB in macrophages induces transcript expression of iNOS and COX-2 [12, 19, 21] . NF-κB is a heterodimeric complex consisting of two subunits, p65 and p50, and can bind to a specific cytokine promoter sequence [3, 10] . NF-κB, which is usually inhibited by IκB, is activated by LPS-induced phosphorylation, and the p65 subunit then functions as a transcription factor and induces expression of specific genes such as that encoding iNOS [27] . In our study, EUC root extract concen- In conclusion, EUC root extract inhibits the expression of COX-2 and iNOS and the production of NO by inhibiting the NF-κB pathway; specifically, the root extract inhibits ERK1/2 and Akt phosphorylation and IκB degradation.
These findings suggest that EUC root extract has potential applications as an anti-inflammatory agent. 
